Active substances

Thyme + mallow›

R05CA10 Respiratory system | Expectorants, excl. combinations with cough suppressants

Indicated for: cough; pharyngeal irritation

Thyrotropin alfa›

H01AB01 Systemic hormonal preparations, excluding sex hormones and insulins | Anterior pituitary lobe hormones and analogues | Thyrotropin

Indicated for: monitoring and diagnosis in thyroid cancer

Tiagabine›

N03AG06 Nervous system | Antiepileptics | Antiepileptics | Fatty acid derivatives

Indicated for: epilepsy

Tianeptine›

N06AX14 Nervous system | Antidepressants | Other antidepressants

Indicated for: depression

Tiapride›

N05AL03 Nervous system | Antipsychotics | Benzamides

Indicated for: behavioral disorders; movement disorders

Tibolone›

G03CX01 Genito urinary system and sex hormones | Estrogens | Other estrogens

Indicated for: menopausal symptoms

Ticagrelor›

B01AC24 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin

Indicated for: prevention of atherothrombotic events

Ticarcillin + clavulanic acid›

J01CR03 Antiinfectives for systemic use | Beta-lactam antibacterials, penicillins | Combinations of penicillins, incl. beta-lactamase inhibitors

Indicated for: bacterial infections

Tick-borne encephalitis vaccine›

J07BA01 Antiinfectives for systemic use | Viral vaccines | Encephalitis vaccines

Indicated for: prevention of tick-borne encephalitis

Ticlopidine›

B01AC05 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin

Indicated for: prevention of atherothrombotic events

Tigecycline›

J01AA12 Antiinfectives for systemic use | Tetracyclines

Indicated for: bacterial infections

Tildrakizumab›

L04AC17 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Interleukin inhibitors

Indicated for: psoriasis

Timolol›

S01ED01 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents

Indicated for: glaucoma; hypertension

Tin-labeled cells›

V09GA06 Various | Cardiovascular system | Technetium (99mtc) compounds

Indicated for: diagnostic imaging

Tincture of arnica flowers›

Indicated for: bruises; local muscle pain

Tinidazole›

P01AB02 Antiparasitic products, insecticides and repellents | Agents against amoebiasis and other protozoal diseases | Nitroimidazole derivatives

Indicated for: bacterial and protozoal infections

Tinzaparin›

B01AB10 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Heparin group

Indicated for: prevention and treatment of thromboembolism

Tiotropium›

R03BB04 Respiratory system | Other drugs for obstructive airway diseases, inhalants | Anticholinergics

Indicated for: asthma; chronic obstructive pulmonary disease

Tiotropium + olodaterol›

R03AL06 Respiratory system | Adrenergics, inhalants | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids

Indicated for: chronic obstructive pulmonary disease

Tipranavir›

J05AE09 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors

Indicated for: HIV-1 infection

Tirofiban›

B01AC17 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin

Indicated for: prevention of atherothrombotic events

Tirzepatide›

A10BX16 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Other blood glucose lowering drugs, excl. insulins

Indicated for: type 2 diabetes mellitus; weight management

Tisagenlecleucel›

L01XL04 Antineoplastic and immunomodulating agents | Other antineoplastic agents | Antineoplastic cell and gene therapy

Indicated for: hematologic malignancies

Tislelizumab›

L01FF09 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors

Indicated for: cancer

Tivozanib›

L01EK03 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors

Indicated for: cancer

Tixagevimab + cilgavimab›

J06BD03 Antiinfectives for systemic use | Immunoglobulins | Antiviral monoclonal antibodies

Indicated for: prevention of COVID-19

Tizanidine›

M03BX02 Musculo-skeletal system | Muscle relaxants | Muscle relaxants, centrally acting agents | Other centrally acting agents

Indicated for: spasticity; muscle spasms

Tobramycin›

S01AA12 Sensory organs | Antiinfectives | Antibiotics

Indicated for: bacterial infections

Tobramycin + dexamethasone›

S01CA01 Sensory organs | Antiinflammatory agents and antiinfectives in combination | Corticosteroids and antiinfectives in combination

Indicated for: inflammatory dermatoses

Tocilizumab›

L04AC07 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Interleukin inhibitors

Indicated for: autoimmune inflammatory diseases